Drug Database
Back to search

Netherlands· NL-a8703198b508

Montelukast OPKO 10 mg tabletten

A montelukast product containing montelukast natrium, registered in Netherlands by OPKO Health Spain S.L.U.. The same ATC class is registered in 19 of our 19 countries.

ATC R03DC03

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedMontelukast OPKO 10 mg tablettenATCR03DC03REGISTER NO.NL-a8703198b508PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about montelukast natriumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Montelukast is registered in 19 of 19 countries.

Countries holding a registration under ATC R03DC03 (montelukast), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 11 of them publish a price we can compare per daily dose
Search montelukast products by name

Montelukast · ATC R03DC03

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of montelukast costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.59 in Italy to $1.71 in Spain — a ×2.9 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Montelukast · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • ES Spain$1.71
  • CH Switzerland$1.41
  • FR France$0.71
  • IT Italy$0.59
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
MONTELUKAST NATRIUM
Manufacturer
OPKO Health Spain S.L.U.
Country
Netherlands (NL)
ATC code
R03DC03
ATC class
Montelukast
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    130712

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

565 interactions on record for montelukast.

Graded by severity as the source publishes them — 101 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check montelukast against other medicinesHow interaction checks work

Montelukast · interactions on record

565 records

  • 101 moderate
  • 464 info

Most severe, free to view

  • MiconazoleA07AC01moderate
  • TroglitazoneA10BG01moderate
  • NateglinideA10BX03moderate
  • NitisinoneA16AX04moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Montelukast in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All montelukast products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Lanair, Montelukast +pharma
  • Belgium · Montelukast Ab, Montelukast Eg
  • Bulgaria · Eфира, Moнтелукаст Акорд
  • Cyprus · Modulair, Montelukast Krka
  • Czechia · Castispir, Monkasta
  • Germany · Monkasta, Montelair Hexal
  • Denmark · Montelukast "sandoz", Montelukast Accord Healthcare
  • Estonia · Monkasta, Montelukast Teva
  • Spain · Monkasta, Montelukast Accord
  • Finland · Montelukast, Montelukast Accord
  • France · Montelukast Accord, Montelukast Accord Healthcare
  • United Kingdom (Northern Ireland) · Montelukast, Montelukast for Children From 6 To 14 Years Accord Healthcare
  • Greece · Apilone, Ascolin
  • Croatia · Melarth, Monkasta
  • Hungary · Eonic, Monalux
  • Ireland · Montelair, Montelukast
  • Iceland · Montelukast Alvogen, Singulair
  • Italy · Aleast Per Bambini Da 2 A 5 Anni, Aleast Per Bambini Da 6 A 14 Anni
  • Lithuania · Monkasta
  • Luxembourg · Montelukast Eurogenerics, Montelukast Ratiopharm
  • Latvia · Monkasta
  • Malta · Actamone, Monkasta
  • Norway · Montelukast Krka, Montelukast Sandoz
  • Poland · Asmenol, Astmodil
  • Portugal · Montelucaste Accord, Montelucaste Alter
  • Romania · Monkasta, Montelukast Arena
  • Sweden · Montelukast Accord, Montelukast Amarox
  • Slovenia · Monkasta, Singulair
  • Slovakia · Astmasan, Belokast

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3c504f44-a946-42e4-9d08-6bb6b08b1c24
GET /v1/drugs/3c504f44-a946-42e4-9d08-6bb6b08b1c24?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h130712_smpc_en.pdf",
  "strength": null,
  "atc_label": "Montelukast",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg130712",
  "excipients": [
    "ASPARTAAM (E 951)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "IJZEROXIDE GEEL (E 172)",
    "IJZEROXIDE ROOD  (E 172)",
    "KERSENSMAAKSTOF",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MANNITOL (D-) (E 421)",
    "MANNITOL (D-) (E 421)"
  ],
  "substances": [
    "MONTELUKAST NATRIUM"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h130712_piluk.pdf",
  "authorised_at": "2024/06/27",
  "procedure_number": "NL/H/5645/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "130712",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about montelukast.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console